Precision Virologics is a St. Louis-based biotech startup.
Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2019 | Grant | $300K | 1 |
National Institutes of Health
|
— | Detail |
| Sep 18, 2018 | Grant | $215.08K | 1 |
National Institutes of Health
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |